Positive COVID-19 test no longer required to prescribe Paxlovid, Lagevrio

On February 1st the FDA revised its emergency use authorizations (EUAs) for 2 antivirals to now allow doctors and pharmacists to prescribe Paxlovid (nirmatrelvir/ritonavir) and Lagevrio (molnupiravir) to patients without a positive test for COVID-19.